Spravato (Esketamine) Treatment

Living with treatment-resistant depression? Brightpoint Psychiatry offers Spravato® (esketamine) treatment in a safe, medically supervised setting, providing an innovative option for adults who haven't found relief with traditional antidepressants.

Brightpoint Psychiatry

General Psychiatrist & AHDH Specialist Located in Carrolton, Texas, USA

Spravato® (Esketamine) Treatment

A New Approach for Treatment-Resistant Depression

For individuals living with depression that has not improved despite trying multiple antidepressant medications, Spravato® (esketamine) may provide another treatment option.

Spravato is an FDA-approved nasal spray treatment used for adults with treatment-resistant depression and certain cases of major depressive disorder. It works differently from traditional antidepressants by targeting the brain's glutamate system, which plays an important role in neural communication and mood regulation.

What Is Spravato?

Spravato contains esketamine, a medication derived from ketamine and administered as a nasal spray under medical supervision.

Unlike many traditional antidepressants that may take weeks to show benefits, Spravato may provide symptom improvement more rapidly for some patients.

Who May Be Eligible?

Spravato may be considered for adults who:

  • Have treatment-resistant depression

  • Have not responded to multiple antidepressants

  • Continue experiencing significant depressive symptoms

  • Meet clinical eligibility requirements

How Spravato Works

Researchers believe Spravato affects NMDA receptors and supports neural connectivity involved in mood regulation. This mechanism differs from traditional antidepressants, making it a unique treatment option.

What to Expect During Treatment

Treatment takes place in a certified medical setting.

The process generally includes:

  1. Clinical evaluation

  2. Eligibility review

  3. Administration of nasal spray

  4. Observation period

  5. Follow-up treatment planning

Patients are monitored following each session as part of established safety protocols.

Benefits of Spravato

  • FDA-approved treatment

  • Different mechanism of action

  • Option for treatment-resistant depression

  • Administered under professional supervision

  • May provide relief for individuals who have not responded to conventional treatments

Frequently Asked Questions

How is Spravato different from traditional antidepressants?

It works through different brain pathways than many standard antidepressants.

Is Spravato covered by insurance?

Many insurance providers offer coverage depending on eligibility requirements.

How long does treatment take?

The treatment schedule varies based on individual clinical needs and provider recommendations.

© Copyright 2026 Brightpoint Psychiatry
Accessibility Notice
Brightpoint Psychiatry Carrollton, TX
Phone: 972-939-1362 | Email: info@brightpointpsychiatry.com | Fax Number: 800-697-6409
Address: 1735 Keller Springs Rd Suite 203 Carrollton TX 75006 United States
Website Designed & Developed by: thedesignmagnet.com